2025-10-09 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the provided data. The report is structured as requested:

## Albemarle Corp (ALB) Analysis

Albemarle Corp is a specialty chemicals manufacturing company.

### 1. Performance Relative to S&P 500 (VOO)

*   **ALB Cumulative Return:** -11.49%
*   **VOO (S&P 500) Cumulative Return:** 99.62%
*   **Absolute Divergence:** -113.11%
*   **Relative Divergence:** 2.3

**Analysis:** ALB has significantly underperformed the S&P 500. The substantial negative divergence indicates considerable weakness relative to the broader market. The relative divergence of 2.3 suggests ALB is positioned at the very low end of its historical divergence range compared to VOO.

**Alpha, Beta Analysis Table:**

| Year       | CAGR     | MDD    | Alpha   | Beta   | Cap(B) |
|------------|----------|--------|---------|--------|--------|
| 2015-2017  | 85.0%    | 68.0%  | 56.0%   | 0.1    | 15.1   |
| 2016-2018  | 9.0%     | 68.0%  | -6.0%   | 0.0    | 9.1    |
| 2017-2019  | -44.0%   | 73.9%  | -66.0%  | 0.1    | 8.6    |
| 2018-2020  | 44.0%    | 79.4%  | 20.0%   | 0.2    | 17.4   |
| 2019-2021  | 149.0%   | 79.4%  | 103.0%  | -0.1   | 27.5   |
| 2020-2022  | 148.0%   | 79.9%  | 149.0%  | 0.5    | 25.5   |
| 2021-2023  | -26.0%   | 81.9%  | -27.0%  | 0.5    | 17.0   |
| 2022-2024  | -152.0%  | 81.9%  | -172.0% | 0.3    | 10.1   |
| 2023-2025  | -233.0%  | 81.9%  | -297.0% | -0.4   | 10.8   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** Highly volatile, with periods of significant growth followed by sharp declines. Recent years show substantial negative growth.
*   **MDD (Maximum Drawdown):** Consistently high, indicating significant risk and price volatility.
*   **Alpha:** Recent Alpha figures are very negative, suggesting significant underperformance relative to the market.
*   **Beta:** Beta values are relatively low, indicating that ALB's price is not highly correlated with the market, however, the last two years are showing negative numbers.
*   **Cap (B):** The company's market capitalization has fluctuated over time.

### 2. Recent Stock Price Movement

*   **Current Price:** 91.69
*   **Previous Close:** 90.53
*   **Change:** 1.28
*   **5-Day Moving Average:** 90.02
*   **20-Day Moving Average:** 83.35
*   **60-Day Moving Average:** 79.56

**Analysis:** The price is above all three moving averages, suggesting a short-term uptrend. The recent positive change in price (1.28) confirms this.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 66.57
*   **PPO:** 1.08
*   **Hybrid Signal:** Buy 100%
*   **Recent Change in Relative Divergence (20-day):** -0.4 (Negative - Short-term decline)
*   **Expected Return (%):** 1466.5

**Analysis:**

*   **MRI:** Despite recent underperformance, the MRI suggests a high investment recommendation. This might be based on longer-term factors not fully reflected in the recent data.
*   **RSI:** The RSI is at 66.57, approaching overbought territory (typically above 70), suggesting the recent price increase may be overextended.
*   **PPO:** A positive PPO indicates that the shorter-term moving average is above the longer-term moving average, confirming the short-term uptrend.
*   **Hybrid Signal:** The "Buy 100%" signal is very strong, indicating a positive outlook based on the combined indicators.
*   **Relative Divergence Change:** The recent decline in relative divergence suggests that ALB's underperformance compared to VOO may be worsening in the short term.
*   **Expected Return:** The exceptionally high expected return suggests potential for significant outperformance relative to the S&P 500 if a long-term investment strategy is pursued.

### 4. Recent News & Significant Events

*   **Analyst Optimism Ahead of Earnings:** News suggests analysts are becoming more optimistic about Albemarle's prospects, particularly regarding lithium.
*   **Catalysts Shaping the Evolving Story:** Articles discuss the factors influencing Albemarle's future.
*   **Decline More Than Market:** Some reports indicate Albemarle has been declining more than the overall market.
*   **Trending Stock:** Albemarle is being watched by investors, suggesting potential volatility.
*   **UBS Adjusts Price Target:** UBS has lowered its price target to $85 while maintaining a neutral rating.
*   **Basic Materials Stocks:** Albemarle is mentioned as a potential stock to beat earnings estimates.

### 4-2. Analyst Opinions

*   **Consensus:** Hold (Mean: 2.64)
*   **Opinions:** 22 analysts
*   **Target Price:** Average: $87.79, High: $200.00, Low: $58.00

**Analysis:** The overall analyst consensus is "Hold," suggesting a neutral outlook. The wide range in target prices reflects uncertainty about the stock's future performance.

### 5. Recent Earnings Analysis

| 날짜       | EPS    | 매출      |
|------------|--------|-----------|
| 2025-08-04 | -0.16  | 1.33 B$   |
| 2025-04-30 | 0      | 1.08 B$   |
| 2024-11-06 | -9.45  | 1.35 B$   |
| 2024-07-31 | -1.96  | 1.43 B$   |
| 2025-08-04 | -1.96  | 1.43 B$   |

**Analysis:** Recent EPS (Earnings Per Share) figures are negative, indicating profitability challenges. Revenue has fluctuated, showing some volatility.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-06-30   | $1.33B     | 14.80%        |
| 2025-03-31   | $1.08B     | 14.51%        |
| 2024-12-31   | $1.23B     | 11.22%        |
| 2024-09-30   | $1.35B     | -7.68%        |
| 2024-06-30   | $1.43B     | -0.74%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-06-30   | $10.24B    | 0.22%    |
| 2025-03-31   | $10.03B    | 0.41%    |
| 2024-12-31   | $9.96B     | 0.76%    |
| 2024-09-30   | $10.24B    | -10.44%   |
| 2024-06-30   | $11.22B    | -1.68%   |

**Analysis:**

*   **Revenue:** Revenue has fluctuated over the past few quarters.
*   **Profit Margin:** Profit margins have been inconsistent, with recent quarters showing positive margins, but previous quarters showing negative margins.
*   **Equity:** Equity has remained relatively stable.
*   **ROE (Return on Equity):** ROE has been volatile, with recent quarters showing positive but low returns, while previous quarters showed negative returns.

### 7. Overall Summary and Recommendation

Albemarle (ALB) presents a mixed picture. While recent price action shows a short-term uptrend, the stock has significantly underperformed the S&P 500. Financial performance has been inconsistent, with fluctuating revenue and profitability. Analyst opinions are neutral ("Hold"), and price targets are widely varied, reflecting uncertainty.

**Key Points:**

*   **Underperformance:** ALB has significantly underperformed the market.
*   **Mixed Signals:** Technical indicators give mixed signals.
*   **Financial Volatility:** Recent earnings and financial data show volatility.
*   **Analyst Uncertainty:** Analyst opinions are neutral with wide-ranging price targets.

**Recommendation:**

Given the underperformance, mixed signals, and analyst uncertainty, a cautious approach is warranted. Consider the following:

*   **For Existing Holders:** Carefully monitor the stock's performance, particularly in relation to the S&P 500. Reassess the investment thesis based on upcoming earnings reports and news.
*   **For Potential Investors:** Conduct thorough due diligence. Understand the risks and potential rewards before investing. Monitor news related to the lithium market, which could significantly impact Albemarle's future performance.
